Product Information
ATORVASTATIN 10 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.0232 per EA under NDC 70710177700. Its NADAC has been published 106 times since Aug 14, 2024.
FDA first approved this application on Nov 20, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710177700
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA206536FDA Approved
11/20/2018
TE Code
AB
On Market Since
6/12/2024
Pharmacological Classes
Price Statistics
The NADAC for ATORVASTATIN 10 MG TABLET has been published 106 times since Aug 14, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0232 per EA |
|---|---|
| All-time high | $0.0302 (Oct 16, 2024) |
| All-time low | $0.0224 (Nov 20, 2024) |
| 52-week high | $0.0263 |
| 52-week low | $0.0232 |
| Median price | $0.0256 |
| Average price | $0.0262 |
| Largest weekly change | +25.3% (Aug 21, 2024) |
| Weeks tracked | 106 |
| Tracking since | Aug 14, 2024 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ATORVASTATIN 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 10 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.0232 per EA (NDC 70710177700), effective Aug 19, 2026.
How has the price of ATORVASTATIN 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for ATORVASTATIN 10 MG TABLET has held within roughly two percent of its current level. It has been tracked across 106 weekly CMS publications since Aug 14, 2024.
What are the highest and lowest recorded NADAC prices for ATORVASTATIN 10 MG TABLET?
Since Aug 14, 2024, the NADAC for ATORVASTATIN 10 MG TABLET has ranged from a low of $0.0224 (Nov 20, 2024) to a high of $0.0302 (Oct 16, 2024), with a median of $0.0256 per EA.
Are there cheaper alternatives to ATORVASTATIN 10 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ATORVASTATIN 10 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ATORVASTATIN 10 MG TABLET?
ATORVASTATIN 10 MG TABLET (NDC 70710177700) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.